Beate Krämer

679 citations

34 papers · 544 indexed · h-index 15

Impact in

Virology top 5%
- Rabies epidemiology and control
Microbiology top 10%
- Microbial infections and disease research

Papers in ⓘ

Molecular Biology 11
- Biochemical and Structural Characterization 4
Neurology 10
- Botulinum Toxin and Related Neurological Disorders 10

Co-authors: Siegfried R. Waldvogel (7 shared papers)Karin Duchow (8 shared papers)Roland Fröhlich (2 shared papers)Karin Weißer (6 shared papers)A Daas (2 shared papers)Eleni Stamellou (1 shared paper)Kay-Martin Hanschmann (5 shared papers)Hans‐Günther Schmalz (1 shared paper)
Journals: Vaccine (5 papers)Biologicals (4 papers)Toxicology in Vitro (4 papers)Angewandte Chemie International Edition (2 papers)Journal of Biotechnology (1 paper)
Partner nations: Germany Netherlands Canada

In The Last Decade

Beate Krämer

32 papers receiving 527 citations

Peers

Countries citing papers authored by Beate Krämer

Since Specialization

Citations

This map shows the geographic impact of Beate Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Krämer more than expected).

Fields of papers citing papers by Beate Krämer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Krämer. The network helps show where Beate Krämer may publish in the future.

Co-authors

The 25 scholars most cited alongside Beate Krämer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beate Krämer Line = papers co-authored together Beate Krämer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation Redox Biology ·Eleni Stamellou, D. Storz, Svetlana Botov, Emmanouil Ntasis, Johannes Wedel, Silvio Sollazzo, Beate Krämer, Willem van Son, Marc A. Seelen, Hans‐Günther Schmalz, Annette M. Schmidt, Mathias Hafner, Benito Yard	2014	73
2	Oxidative Coupling Reactions Mediated by MoCl₅ Leading to 2,2′‐Cyclolignans: The Specific Role of HCl European Journal of Organic Chemistry ·Beate Krämer, Roland Fröhlich, Siegfried R. Waldvogel	2003	50
3	Highly Modular Construction of Differently Substituted Dihydrodibenzo[a,c]cycloheptenes: Fast and Efficient Access to Derivatives of 2,2′‐Cyclo‐7,8′‐neolignans Angewandte Chemie International Edition ·Beate Krämer, Siegfried R. Waldvogel	2004	49
4	Highly Selective Formation of Eight-Membered-Ring Systems by Oxidative Cyclization with Molybdenum PentachlorideâAn Environmentally Friendly and Inexpensive Access to 2,2â²-Cyclolignans The work was supported by the Deutschen Forschungsgemeinschaft and H. C. Starck (Goslar, Germany) by a donation of MoCl5. We particularly thank Prof. Dr. Dieter Hoppe for fruitful discussions and support in this project. Angewandte Chemie International Edition ·Beate Krämer, Anne Averhoff, Siegfried R. Waldvogel	2002	46
5	The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines Biologicals ·Beate Krämer, H. Schildger, Heike A. Behrensdorf-Nicol, K. M. Hanschmann, Karin Duchow	2009	38
6	Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use. PubMed ·Beate Krämer, L Bruckner, A Daas, C Milne	2010	30
7	Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens Journal of Virology ·Renata da Fontoura Budaszewski, Andrew W. Hudacek, Bevan Sawatsky, Beate Krämer, Xiangping Yin, Matthias J. Schnell, Veronika von Messling	2017	28
8	Elimination of abnormal toxicity test for sera and certain vaccines in the European Pharmacopoeia Vaccine ·Michael Schwanig, Margit Nagel, Karin Duchow, Beate Krämer	1997	24
9	Hochmodularer Aufbau unterschiedlich substituierter Dihydrodibenzo[a,c]cycloheptene: ein schneller und effizienter Zugang zu Derivaten des 2,2′‐Cyclo‐7,8′‐neolignans Angewandte Chemie ·Beate Krämer, Siegfried R. Waldvogel	2004	23
10	Hochselektive Achtringbildung durch oxidative Cyclisierung mit MolybdÃ¤npentachlorid â ein umweltfreundlicher und preiswerter Zugang zu 2,2â²-Cyclolignanen Diese Arbeit wurde unterstÃ¼tzt von der Deutschen Forschungsgemeinschaft und der Firma H. C. Starck (Goslar) durch eine MoCl5-Spende. Wir danken besonders Prof. Dr. Dieter Hoppe fÃ¼r die fruchtbaren Diskussionen und seine UnterstÃ¼tzung in diesem Projekt. Angewandte Chemie ·Beate Krämer, Anne Averhoff, Siegfried R. Waldvogel	2002	23
11	Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles Viruses ·Sarah Moeschler, Samira Locher, Karl‐Klaus Conzelmann, Beate Krämer, Gert Zimmer	2016	23
12	An in vitro assay for detection of tetanus neurotoxin activity: Using antibodies for recognizing the proteolytically generated cleavage product Toxicology in Vitro ·Birgit Kegel, Heike A. Behrensdorf-Nicol, Ursula Bonifas, K. Silberbach, J Klimek, Beate Krämer, Karin Weißer	2007	18
13	Residual enzymatic activity of the tetanus toxin light chain present in tetanus toxoid batches used for vaccine production Vaccine ·Heike A. Behrensdorf-Nicol, Birgit Kegel, Ursula Bonifas, K. Silberbach, J Klimek, Karin Weißer, Beate Krämer	2008	17
14	In vitro potency determination of botulinum neurotoxin B based on its receptor-binding and proteolytic characteristics Toxicology in Vitro ·Emina Wild, Ursula Bonifas, J Klimek, Jan‐Hendrik Trösemeier, Beate Krämer, Birgit Kegel, Heike A. Behrensdorf-Nicol	2016	17
15	Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: Applicability as alternative method for the safety testing of tetanus toxoids during vaccine production Vaccine ·Heike A. Behrensdorf-Nicol, Ursula Bonifas, Kay-Martin Hanschmann, Beate Krämer, Karin Weißer	2013	14
16	In vitro determination of tetanus toxicity by an endopeptidase assay linked to a ganglioside-binding step Toxicology in Vitro ·Heike A. Behrensdorf-Nicol, Ursula Bonifas, Birgit Kegel, K. Silberbach, Beate Krämer, Karin Weißer	2009	12
17	A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use Biologicals ·Beate Krämer, Elisabeth Kamphuis, Kay-Martin Hanschmann, Catherine Milne, A Daas, Karin Duchow	2013	10
18	In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics Toxicology in Vitro ·Heike A. Behrensdorf-Nicol, Emina Wild, Ursula Bonifas, J Klimek, Kay-Martin Hanschmann, Beate Krämer, Birgit Kegel	2018	7
19	[Is the abnormal toxicity test still relevant for the safety of vaccines, sera and immunoglobulins?] PubMed ·Beate Krämer, Margit Nagel, Karin Duchow, Michael Schwanig, Klaus Cußler	1996	7
20	In vitro determination of specific toxicity in tetanus vaccines. PubMed ·Birgit Kegel, Ursula Bonifas, K. Silberbach, Beate Krämer, Karin Weißer	2002	7

About Beate Krämer

Beate Krämer is a scholar working on Molecular Biology, Neurology, Organic Chemistry, Virology and Epidemiology, having authored 34 papers that have together received 544 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (10 papers), Rabies epidemiology and control (7 papers), Microbial infections and disease research (6 papers), Virology and Viral Diseases (5 papers), Diphtheria, Corynebacterium, and Tetanus (4 papers), Streptococcal Infections and Treatments (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Biochemical and Structural Characterization (4 papers). The work is most often cited by research in Virology (94 citations), Microbiology (62 citations), Endocrinology (41 citations), Organic Chemistry (185 citations) and Neurology (76 citations). Beate Krämer has collaborated with scholars based in Germany, Netherlands and Canada. Frequent co-authors include Siegfried R. Waldvogel, Karin Duchow, Roland Fröhlich, Karin Weißer, A Daas, Eleni Stamellou, Kay-Martin Hanschmann, Hans‐Günther Schmalz, Benito Yard and Mathias Hafner. Their work appears in journals such as Vaccine, Biologicals, Toxicology in Vitro, Angewandte Chemie International Edition and Journal of Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact